RhumbLine Advisers’s Evolus EOLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $475K | Sell |
68,376
-350
| -0.5% | -$2.07K | ﹤0.01% | 2803 |
|
|
2026
Q1 | $282K | Sell |
68,726
-1,323
| -2% | -$6.41K | ﹤0.01% | 2937 |
|
|
2025
Q4 | $466K | Sell |
70,049
-12,677
| -15% | -$85.9K | ﹤0.01% | 2703 |
|
|
2025
Q3 | $508K | Sell |
82,726
-2,367
| -3% | -$18.5K | ﹤0.01% | 2687 |
|
|
2025
Q2 | $784K | Buy |
85,093
+1,657
| +2% | +$17K | ﹤0.01% | 2372 |
|
|
2025
Q1 | $1M | Buy |
83,436
+3,287
| +4% | +$43K | ﹤0.01% | 2165 |
|
|
2024
Q4 | $885K | Buy |
80,149
+1,762
| +2% | +$24.8K | ﹤0.01% | 2311 |
|
|
2024
Q3 | $1.27M | Sell |
78,387
-3,052
| -4% | -$42.7K | ﹤0.01% | 2142 |
|
|
2024
Q2 | $884K | Buy |
81,439
+17,442
| +27% | +$215K | ﹤0.01% | 2312 |
|
|
2024
Q1 | $896K | Sell |
63,997
-5,149
| -7% | -$66.9K | ﹤0.01% | 2310 |
|
|
2023
Q4 | $728K | Buy |
69,146
+5,310
| +8% | +$47.5K | ﹤0.01% | 2443 |
|
|
2023
Q3 | $583K | Buy |
63,836
+660
| +1% | +$5.92K | ﹤0.01% | 2521 |
|
|
2023
Q2 | $459K | Buy |
63,176
+7,556
| +14% | +$65.2K | ﹤0.01% | 2741 |
|
|
2023
Q1 | $471K | Buy |
55,620
+1,180
| +2% | +$10.7K | ﹤0.01% | 2459 |
|
|
2022
Q4 | $409K | Buy |
54,440
+2,051
| +4% | +$15.9K | ﹤0.01% | 2558 |
|
|
2022
Q3 | $422K | Buy |
52,389
+4,736
| +10% | +$50.2K | ﹤0.01% | 2571 |
|
|
2022
Q2 | $553K | Buy |
47,653
+13,396
| +39% | +$158K | ﹤0.01% | 2452 |
|
|
2022
Q1 | $384K | Buy |
34,257
+3,603
| +12% | +$30.7K | ﹤0.01% | 2538 |
|
|
2021
Q4 | $200K | Buy |
30,654
+306
| +1% | +$2.1K | ﹤0.01% | 2834 |
|
|
2021
Q3 | $231K | Buy |
30,348
+1,397
| +5% | +$14.4K | ﹤0.01% | 2853 |
|
|
2021
Q2 | $366K | Buy |
28,951
+4,572
| +19% | +$50.3K | ﹤0.01% | 2708 |
|
|
2021
Q1 | $317K | Sell |
24,379
-710
| -3% | -$6.54K | ﹤0.01% | 2684 |
|
|
2020
Q4 | $84K | Buy |
25,089
+3,418
| +16% | +$12.8K | ﹤0.01% | 2983 |
|
|
2020
Q3 | $85K | Sell |
21,671
-4,240
| -16% | -$15.5K | ﹤0.01% | 2893 |
|
|
2020
Q2 | $137K | Buy |
25,911
+8,338
| +47% | +$38.4K | ﹤0.01% | 2883 |
|
|
2020
Q1 | $73K | Buy |
17,573
+1,125
| +7% | +$9.53K | ﹤0.01% | 2829 |
|
|
2019
Q4 | $200K | Buy |
16,448
+1,651
| +11% | +$23.3K | ﹤0.01% | 2749 |
|
|
2019
Q3 | $231K | Buy |
14,797
+1,953
| +15% | +$32K | ﹤0.01% | 2696 |
|
|
2019
Q2 | $188K | Buy |
12,844
+2,003
| +18% | +$39.7K | ﹤0.01% | 2801 |
|
|
2019
Q1 | $245K | Sell |
10,841
-10
| -0.1% | -$216 | ﹤0.01% | 2653 |
|
|
2018
Q4 | $129K | Buy |
+10,851
| New | +$155K | ﹤0.01% | 2841 |
|
Other funds holding EOLS
NCM
B
FLSM
PA
SCM
RhumbLine Advisers's EOLS Position: Q2 2026 in Review
RhumbLine Advisers reduced its Evolus (EOLS) stake by 0.51% in Q2 2026, selling an estimated $2.07K and leaving 68,376 shares worth $475K. The position accounts for ﹤0.01% of the portfolio, ranked #2803.
RhumbLine Advisers first reported a position in EOLS in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.27M in Q3 2024. 158 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.
- RhumbLine Advisers held 68,376 shares of Evolus worth $475K as of Q2 2026.
- RhumbLine Advisers sold 350 Evolus shares in Q2 2026, an estimated $2.07K.
- Evolus made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #2803 holding.
- RhumbLine Advisers first reported a position in Evolus in Q4 2018 and has held it in 31 quarters since.
- RhumbLine Advisers's Evolus position peaked at $1.27M in Q3 2024.
- 158 funds tracked by Wall St. Rank held Evolus as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.